Intuitive Surgical Inc (ISRG)vsAnbio Biotechnology Class A Ordinary Shares (NNNN)
ISRG
Intuitive Surgical Inc
$369.15
+2.41%
HEALTHCARE · Cap: $132.26B
NNNN
Anbio Biotechnology Class A Ordinary Shares
$6.34
-2.61%
HEALTHCARE · Cap: $283.98M
Smart Verdict
WallStSmart Research — data-driven comparison
Intuitive Surgical Inc generates 127513% more annual revenue ($11.03B vs $8.65M). NNNN leads profitability with a 74.1% profit margin vs 28.4%. ISRG trades at a lower P/E of 41.3x. ISRG earns a higher WallStSmart Score of 66/100 (B-).
ISRG
Strong Buy66
out of 100
Grade: B-
NNNN
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+80.6%
Fair Value
$1899.56
Current Price
$369.15
$1530.41 discount
Intrinsic value data unavailable for NNNN.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 33.6%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Keeps 28 of every $100 in revenue as profit
18.5% revenue growth
Earnings expanding 26.5% YoY
Keeps 74 of every $100 in revenue as profit
Strong operational efficiency at 59.1%
Revenue surging 73.9% year-over-year
Every $100 of equity generates 24 in profit
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Trading at 9.2x book value
2.8% earnings growth
Smaller company, higher risk/reward
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : ISRG
The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.4% and operating margin at 33.6%. Revenue growth of 18.5% demonstrates continued momentum.
Bull Case : NNNN
The strongest argument for NNNN centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 74.1% and operating margin at 59.1%. Revenue growth of 73.9% demonstrates continued momentum.
Bear Case : ISRG
The primary concerns for ISRG are PEG Ratio, P/E Ratio. A P/E of 41.3x leaves little room for execution misses.
Bear Case : NNNN
The primary concerns for NNNN are Price/Book, EPS Growth, Market Cap. A P/E of 43.1x leaves little room for execution misses.
Key Dynamics to Monitor
NNNN is growing revenue faster at 73.9% — sustainability is the question.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ISRG scores higher overall (66/100 vs 51/100), backed by strong 28.4% margins and 18.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Intuitive Surgical Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
Anbio Biotechnology Class A Ordinary Shares
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. The company is headquartered in Frankfurt am Main, Germany.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?